Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas [NA]

View source ↗

Summary

Clinical trial investigating T2* MRI imaging and blood biomarker testing to predict changes and progression in malignant glioma. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: John M. Buatti | Conditions: Malignant Glioma | NA | Status: RECRUITING